According to Avadel Pharmaceuticals 's latest financial reports the company's total liabilities are $76.95 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $76.95 M | -50% |
2022-12-31 | $0.15 B | -8.93% |
2021-12-31 | $0.16 B | 13.16% |
2020-12-31 | $0.14 B | -17.31% |
2019-12-31 | $0.18 B | -3.67% |
2018-12-31 | $0.18 B | 11.82% |
2017-12-31 | $0.16 B | -17.56% |
2016-12-31 | $0.20 B | 39.37% |
2015-12-31 | $0.14 B | -2.25% |
2014-12-31 | $0.14 B | 18.72% |
2013-12-31 | $0.12 B | 44.88% |
2012-12-31 | $86.8 M | 119.17% |
2011-12-31 | $39.6 M | 3.39% |
2010-12-31 | $38.3 M | -22.5% |
2009-12-31 | $49.43 M | 14.12% |
2008-12-31 | $43.31 M | -7.4% |
2007-12-31 | $46.77 M | 11.72% |
2006-12-31 | $41.86 M | 11.06% |
2005-12-31 | $37.69 M | 30.66% |
2004-12-31 | $28.85 M | -18.02% |
2003-12-31 | $35.19 M | 226.14% |
2002-12-31 | $10.79 M | 1.46% |
2001-12-31 | $10.63 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | 708.84% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $12.01 M | -84.39% | ๐บ๐ธ USA |